Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;27(4):1072-8.
doi: 10.3892/or.2011.1605. Epub 2011 Dec 21.

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas

Ping Zhan  1 , Xiao-Kun Shen, Qian Qian, Qin Wang, Ji-Ping Zhu, Yu Zhang, Hai-Yan Xie, Chuen-Hua Xu, Ke-Ke Hao, Wei Hu, Ning Xia, Guo-Jun Lu, Li-Ke Yu
Affiliations

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas

Ping Zhan et al. Oncol Rep. 2012 Apr.

Abstract

Caveolin-1 (cav-1) has been implicated in the development of human cancers. However, the distribution of cav-1 in non-small cell lung cancer (NSCLC) and its significance require further study. Real-time PCR and Western blot assays were performed to detect cav-1 mRNA and protein levels in tumor tissues (TT) and matched tumor-free tissues (TF). The protein expression in 115 paraffin-embedded blocks was examined by immunohistochemical staining (IHC). Correlations between cav-1 mRNA and protein expression by IHC and clinicopathological features were statistically evaluated. For the 136 patients examined, the levels of cav-1 mRNA and protein expression were significantly lower in lung TT compared to matched TF (P<0.05). High cav-1 expression was detected in 60 of 115 (52.2%) NSCLC tissues and this level was significantly lower than cav-1 expression in non-cancerous lung tissues (15 of 19, 78.9%, P<0.05). Up-regulation of cav-1 mRNA expression in lung adenocarcinoma (AC) (29.7%) was higher than that observed in lung squamous cell carcinoma (SCC) (15.8%). Statistical analysis of the correlation between cav-1 protein expression and clinical features showed a statistical association with poorer N-stage (P=0.032) and higher pathological TNM stage (P=0.012) in lung AC patients, that was not found in lung SCC patients. Moreover, lung AC patients with higher cav-1 expression showed significantly shorter life-spans than those with lower cav-1 expression (P=0.032, log-rank test). The levels of cav-1 mRNA and protein expression were significantly lower in lung cancers when compared to matched TF or non-cancerous lung tissues. The higher protein expression correlated with the advanced pathological stage and shorter survival rates in lung AC patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The relative level of cav-1 mRNA in 136 lung TT and TF samples (P<0.05).
Figure 2
Figure 2
Western blot analysis of the protein level of cav-1 in TT and the paired TF form 4 representative NSCLC cases. β-actin was used to normalize for any differences in protein loading between lanes. The column of the histogram represents the relative level of the cav-1 protein.
Figure 3
Figure 3
IHC of cav-1 protein expression in lung TT. (A) The positive immunoreactivity of cav-1 was localized in the membrane and the intracytoplasm of the lung AC. (B) The positive immunoreactivity of cav-1 was localized in fibroblasts. (C) Bronchial epithelium and smooth muscle cells showed positive staining for cav-1. (D) Negative expression of cav-1 in lung AC.
Figure 4
Figure 4
Survival analysis stratified by the status of the cav-1 protein expression and histological types. (A) Patients whose tumors had high cav-1 protein expression showed shorter overall survival than patients whose tumors had lower cav-1 protein expression, but the result was not statistically significant (P=0.342; log-rank test), (B) In all lung AC patients with higher cav-1 expression, significantly shorter OS was found when compared with those that had lower cav-1 expression levels (P=0.032; log-rank test).
Figure 4
Figure 4
Survival analysis stratified by the status of the cav-1 protein expression and histological types. (A) Patients whose tumors had high cav-1 protein expression showed shorter overall survival than patients whose tumors had lower cav-1 protein expression, but the result was not statistically significant (P=0.342; log-rank test), (B) In all lung AC patients with higher cav-1 expression, significantly shorter OS was found when compared with those that had lower cav-1 expression levels (P=0.032; log-rank test).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123:21–49. - PubMed
    1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–594. - PMC - PubMed
    1. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest. 2007;132:29S–55S. - PubMed
    1. Paesmans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol. 1995;13:1221–1230. - PubMed
    1. Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats. Cell. 1992;68:673–682. - PubMed

Publication types

MeSH terms